Antiviral treatment for cirrhosis due to hepatitis C: a review
Singap. med. j
; Singap. med. j;: 231-235, 2012.
Article
de En
| WPRIM
| ID: wpr-334519
Bibliothèque responsable:
WPRO
ABSTRACT
Chronic hepatitis C infection is an important cause of cirrhosis and hepatocellular carcinoma (HCC). Antiviral therapy (AVT) for patients with cirrhosis due to hepatitis C may retard the progression of cirrhosis and prevent both the development of HCC as well as the recurrence of hepatitis C following liver transplantation. This review highlights the issues associated with AVT for patients with compensated and decompensated cirrhosis due to hepatitis C virus.
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Antiviraux
/
Virologie
/
Transplantation hépatique
/
Hepacivirus
/
Carcinome hépatocellulaire
/
Évolution de la maladie
/
Hépatite C chronique
/
Utilisations thérapeutiques
/
Traitement médicamenteux
/
Prévention secondaire
Limites du sujet:
Humans
langue:
En
Texte intégral:
Singap. med. j
Année:
2012
Type:
Article